Rapid increase in Omicron infections in England during December 2021: REACT-1 study.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
25 03 2022
Historique:
pubmed: 9 2 2022
medline: 6 4 2022
entrez: 8 2 2022
Statut: ppublish

Résumé

The unprecedented rise in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during December 2021 was concurrent with rapid spread of the Omicron variant in England and globally. We analyzed the prevalence of SARS-CoV-2 and its dynamics in England from the end of November to mid-December 2021 among almost 100,000 participants in the REACT-1 study. Prevalence was high with rapid growth nationally and particularly in London during December 2021, with an increasing proportion of infections due to Omicron. We observed large decreases in swab positivity among mostly vaccinated older children (12 to 17 years) relative to unvaccinated younger children (5 to 11 years), and in adults who received a third (booster) vaccine dose versus two doses. Our results reinforce the importance of vaccination and booster campaigns, although additional measures have been needed to control the rapid growth of the Omicron variant.

Identifiants

pubmed: 35133177
doi: 10.1126/science.abn8347
pmc: PMC8939772
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1406-1411

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19012
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Références

Wellcome Open Res. 2020 Aug 25;5:200
pubmed: 33997297
Science. 2021 May 28;372(6545):990-995
pubmed: 33893241
Genome Med. 2021 Feb 9;13(1):21
pubmed: 33563320
Science. 2021 Dec 17;374(6574):eabl9551
pubmed: 34726481
Lancet Respir Med. 2022 Apr;10(4):355-366
pubmed: 35085490
N Engl J Med. 2021 Dec 9;385(24):e84
pubmed: 34614326

Auteurs

Paul Elliott (P)

School of Public Health, Imperial College London, London, UK.
MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, London, UK.
National Institute for Health Research Imperial Biomedical Research Centre, London, UK.
Health Data Research (HDR) UK, Imperial College London, London, UK.
UK Dementia Research Institute, Imperial College London, London, UK.

Barbara Bodinier (B)

School of Public Health, Imperial College London, London, UK.
MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.

Oliver Eales (O)

School of Public Health, Imperial College London, London, UK.
MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.

Haowei Wang (H)

School of Public Health, Imperial College London, London, UK.
MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.

David Haw (D)

School of Public Health, Imperial College London, London, UK.
MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.

Joshua Elliott (J)

Imperial College Healthcare NHS Trust, London, UK.
Department of Infectious Disease, Imperial College London, London, UK.

Matthew Whitaker (M)

School of Public Health, Imperial College London, London, UK.
MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.

Jakob Jonnerby (J)

School of Public Health, Imperial College London, London, UK.
National Heart and Lung Institute, Imperial College Healthcare NHS Trust, London, UK.

David Tang (D)

School of Public Health, Imperial College London, London, UK.
MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.

Caroline E Walters (CE)

School of Public Health, Imperial College London, London, UK.
MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.

Christina Atchison (C)

School of Public Health, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, London, UK.

Peter J Diggle (PJ)

Health Data Research (HDR) UK, Imperial College London, London, UK.
CHICAS, Lancaster Medical School, Lancaster University, Lancaster, UK.

Andrew J Page (AJ)

Quadram Institute, Norwich, UK.

Deborah Ashby (D)

School of Public Health, Imperial College London, London, UK.

Wendy Barclay (W)

Department of Infectious Disease, Imperial College London, London, UK.

Graham Taylor (G)

Department of Infectious Disease, Imperial College London, London, UK.

Helen Ward (H)

School of Public Health, Imperial College London, London, UK.
Imperial College Healthcare NHS Trust, London, UK.
National Institute for Health Research Imperial Biomedical Research Centre, London, UK.
MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.

Ara Darzi (A)

Imperial College Healthcare NHS Trust, London, UK.
National Institute for Health Research Imperial Biomedical Research Centre, London, UK.
Institute of Global Health Innovation, Imperial College London, London, UK.

Graham S Cooke (GS)

Imperial College Healthcare NHS Trust, London, UK.
National Institute for Health Research Imperial Biomedical Research Centre, London, UK.
Department of Infectious Disease, Imperial College London, London, UK.

Marc Chadeau-Hyam (M)

School of Public Health, Imperial College London, London, UK.
MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.

Christl A Donnelly (CA)

School of Public Health, Imperial College London, London, UK.
MRC Centre for Global infectious Disease Analysis and Jameel Institute, Imperial College London, London, UK.
Department of Statistics, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH